Four panel types were tested, consisting of two secondary-bonded skin stiffener designs in both undamaged and pre-damaged configurations.
Four yoghurts were tested, consisting of a control (4% protein, no fibre), 2 medium protein (MP) (∼7% protein, 0.5% fiber) and a high protein (HP) (12.9% protein, 0.5% fiber) product.
Different interval sizes were tested, consisting of 20, 40, 60 or 80 markers, corresponding on average across the genome respectively to 1.3, 2.6, 3.9 and 5.3 Mb.
In ∼40 different datasets we tested, consisting of a variety of ChIP-Seq, methylation and control/input DNA, the phantom peak occurred with varying strengths.
In this study, a group-intervention was tested consisting of fifteen two-hour weekly sessions and contained two components (cognitive appraisal and coping strategies).
Out of the 53 individuals, 44 respective lymphoblastoid cell lines were tested, consisting of 21 affected individuals (16 male and 5 female), 12 fathers, 6 mothers and 5 unaffected siblings.
